EASY BIO,Inc. (KOSDAQ:353810)
6,570.00
-10.00 (-0.15%)
Jun 10, 2026, 3:30 PM KST
EASY BIO,Inc. Revenue
EASY BIO,Inc. had revenue of 130.69B KRW in the quarter ending March 31, 2026, with 11.77% growth. This brings the company's revenue in the last twelve months to 490.70B, up 11.05% year-over-year. In the year 2025, EASY BIO,Inc. had annual revenue of 476.94B with 24.10% growth.
Revenue (ttm)
490.70B
Revenue Growth
+11.05%
P/S Ratio
0.44
Revenue / Employee
3.72B
Employees
132
Market Cap
217.68B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 476.94B | 92.61B | 24.10% |
| Dec 31, 2024 | 384.33B | 218.95B | 132.39% |
| Dec 31, 2023 | 165.39B | 9.83B | 6.32% |
| Dec 31, 2022 | 155.56B | 26.10B | 20.16% |
| Dec 31, 2021 | 129.46B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bioneer | 338.01B |
| Macrogen | 199.60B |
| BINEX | 164.00B |
| GC Cell | 163.35B |
| JETEMA, | 77.07B |
| HLB Therapeutics | 67.56B |
| Anterogen.Co.,Ltd. | 8.06B |
| Genexine | 5.81B |